
Elite Pharmaceuticals Inc Investor Relations Material
Latest events

Q3 2025
Elite Pharmaceuticals Inc
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Elite Pharmaceuticals Inc
Access all reports
Elite Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development, manufacture, and distribution of niche generic and oral controlled-release medications. The company primarily targets the opioid abuse-deterrent and extended-release segments of the pharmaceutical market, offering treatments across a variety of therapeutic areas. Elite Pharmaceuticals specializes in developing formulations that address controlled substance regulations and the potential for abuse. The company’s business model includes both the commercialization of its own products and contract manufacturing services for third-party pharmaceutical companies. The company is headquartered in Northvale, New Jersey, and its shares are listed on the OTCQB.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ELTP
Country
🇺🇸 United States